SCWO:NASDAQ374Water Inc. Analysis
Data as of 2026-05-26 - not real-time
$2.43
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: SCWO is trading above its 20‑day moving average but remains under the 50‑day and 200‑day averages, signaling a short‑term pullback within a longer‑term downtrend. The RSI sits near the mid‑range, the MACD histogram has turned slightly positive, yet volume is declining and 30‑day volatility exceeds 70%, indicating fragile price action. Fundamentals: The company reports negative earnings, zero profit margins, and a steep negative cash‑flow profile, while valuation multiples (price‑to‑book >11x, price‑to‑sales ~190x) are dramatically above industry norms.
Operational catalysts: Recent news highlights the rollout of a recurring‑revenue platform, the first commercial deployment of its mobile AirSCWO system, and improving gross margins on PFAS projects, suggesting potential upside if revenue scaling materializes. However, high beta (~3) and a historic drawdown of over 70% amplify downside risk, especially in an environment of extreme market greed.
Operational catalysts: Recent news highlights the rollout of a recurring‑revenue platform, the first commercial deployment of its mobile AirSCWO system, and improving gross margins on PFAS projects, suggesting potential upside if revenue scaling materializes. However, high beta (~3) and a historic drawdown of over 70% amplify downside risk, especially in an environment of extreme market greed.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below key longer‑term moving averages
- declining volume and high volatility
- significant valuation disparity to peers
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential revenue lift from recurring‑revenue platform
- first commercial deployment indicating market traction
- ongoing cash‑flow deficits and high leverage
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- long‑term environmental regulation tailwinds
- uncertain profitability despite margin improvements
- elevated systematic risk reflected by high beta
Key Metrics & Analysis
Financial Health
Revenue Growth1.50%
P/E Ratio-40.5
ROE-269.13%
ROA-101.72%
Debt/Equity45.37
P/B Ratio11.6
Op. Cash Flow$-13340069
Free Cash Flow$-10473195
Industry P/E29.7
Technical Analysis
TrendBearish
RSI47.6
Support$2.10
Resistance$3.06
MA 20$2.37
MA 50$2.74
MA 200$3.01
MACDBullish
VolumeDecreasing
Fear & Greed Index91.64
Valuation
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.99
Volatility77.48%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.